James G. Todt, RPAC

James Todt practices at Glens Falls Broad Street Medical Center in Glens Falls, New York.

James Todt's NPI, 1922177294, was assigned on November 8, 2006. James Todt holds New York license 005204-1.

James Todt's primary practice is Glens Falls Broad Street Medical Center, at 2 Broad Street Plz, Glens Falls, NY 12801 in Warren County. The practice phone is (518) 926-1770.

James Todt's primary practice is Glens Falls Broad Street Medical Center in Glens Falls, New York. James Todt is also affiliated with Glens Falls Hospital. The medical group on file is Glens Falls Hospital. Dmand AI also links James Todt to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where James Todt practices, 4 sites in all. Vendor and product names are available with a free account.

Surgical is James Todt's primary specialty in the NPI Registry, under taxonomy code 363AS0400X. James Todt is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). James Todt is licensed in New York.

Dmand AI lists arthritis, bladder disease, enlarged prostate, joint pain, lower back pain, muscle pain, fibromyalgia, and limb pain, tendon and ligament injury and UTI among the conditions James Todt treats.

CMS data shows 535 Medicare services from James Todt across 6 procedure codes in 2024, for 356 Medicare patients. Medicare paid $18,325 for them.

CMS counts 356 Medicare patients who saw James Todt in 2024. The largest group is 65 to 74, with 132 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 22% are also on Medicaid. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts James Todt's median patient age at 68, with 26% women.

In 2024, James Todt wrote 1,490 Medicare Part D claims for 381 patients. 87% of them were for generic drugs. CMS names the drug for 1,395 of them, across 20 drugs with 11 or more claims each, at $249,657 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for James Todt for performance year 2024, reported through an alternative payment model (APM). James Todt accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists James Todt as offering telehealth.

CMS Open Payments shows 61 general payments to James Todt from 14 drug and device companies in 2025. Food and beverage make up the largest share, 57% of the total. Boston Scientific Corporation paid the most, $1,665.